Engineered Toxin Bodies - Next Generation Immunotoxins
Joined October 2014
- Tweets 11
- Following 151
- Followers 192
- Likes 0
Photos and videos
15 Aug 2022
Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results globenewswire.com/news-relea…
1
2
18 Nov 2019
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants ir.mtem.com/news-releases/ne…
1
2
28 Mar 2019
Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients $MTEM ir.mtem.com/news-releases/ne…
1
3
19 Sep 2018
Molecular Templates $MTEM Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
ir.mtem.com/news-releases/ne…
2
1
3 Aug 2017
Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration: bit.ly/2w9ZxAu @Moltemp $MTEM
1
1
2 Aug 2017
Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements: bit.ly/2w6gBYj $MTEM
3
2
6 Apr 2016
MTEM to Present Clinical & Preclinical Data for MT-3724 and Next-Gen Engineered Toxin Bodies bit.ly/1oBN43t #AACR16 #oncology #MTEM
1
2
8 Oct 2015
MTEM Collaborates with MD Anderson Cancer Center on MT-3724 in Aggressive Lymphomas #MDACC #Cancer #DLBCL #MTEM mwne.ws/1VEsZJ2
3
3
16 Apr 2015
MTEM to present data at #AACR15 on de-immunization technology and novel immuno-oncology approach (antigen seeding) bit.ly/1E5KhWT